Digitek Recall Lawsuits

On April 25, 2008, a nationwide Digitek Tablet Recall was issued for all lots of the heart medication. Manufacturing problems caused some tablets to contain twice as much of the active ingredient as is appropriate. This could result in digitalis toxicity in patients with impaired kidney function, which is a serious and potentially fatal illness.

STATUS OF DIGITEK LITIGATION: Individual lawsuits and Digitek class actions are currently pending. All of the federal Digitek litigation has been consolidated in an MDL in the Southern District of West Virginia. Digitek lawyers are continuing to review potential cases for individuals who suffered side effects of double strength tablets.

>>HAVE A POTENTIAL DIGITEK LAWSUIT REVIEWED<<

MANUFACTURER: Actavis Totowa, formerly known as Amide Pharmaceutical, Inc., a division of Actavis Group

DISTRIBUTORS: Mylan Pharmaceuticals and UDL Laboratories, Inc.

BRANDS: Sold under “Bertek” and “UDL” brands

OVERVIEW OF DIGITEK LAWSUITS: Digitek (Digoxin Tablets), also sometimes referred to as digitalis, is a heart medication used to treat heart failure, atrial fibrillation and atrial flutter. The recall was initiated by Actavis after the manufacturer received several reports of severe illnesses and serious injuries which were consistent with over medication. It has been determined that some of the tablets sold could be double the appropriate thickness and contain twice the approved level of active ingredient.

As a result of the defectively manufactured Digitek tablets, users with decreased kidney function, including those with renal failure or possibly even dehydration, may have digitalis accumulate in the body when it is not excreted as normal through urine. This could lead to a serious and potentially fatal illness known as “digitalis toxicity”.

The Digitek recall has been labeled a Class 1 nationwide recall, since use of the digonex tablets carries a substantial risk of serious or fatal injury.

Digitek tablets represent about half of the supply of digoxin in the United States. Other trade names for Digoxin include Lanoxin and Lanoxicaps, neither of which have been associated with this recall.

DIGITALIS TOXICITY: Use of recalled Digitek which contain twice the active ingredient could lead to digitalis toxicity, especially among those suffering from renal failure. Digitalis toxicity is a complication of digitalis therapy which can occur after one use or chronic overmedication. It is caused by high levels of digitalis in the body. The outcomes from digitalis toxicity can vary, but possible complications can include arrhythmias, heart failure or death.

Digitalis Toxicity Symptoms could include:

• Unusual Vision Changes (Halos, Bright Spots, Changes in Color Perception, Blind Spots, Blurred Vision)
• Confusion or Dizziness
• Nausea, Vomitting, Diarrhea, Loss of Appetite
• Palpitations or Irregular Heart Beat
• Changes in Urine Output
• Swelling
• Difficulty Breathing

Injured? Have a Claim Reviewed by Digitek Lawyers

Digitek recall lawsuits are being reviewed by lawyers on behalf of individuals who have suffered injuries as a result of defective Digitek tablets. Submit information about injuries suffered by you, a friend or family to have a potential case reviewed by Digitek Recall Lawyers.